🇺🇸 FDA
Pipeline program

LUCAR-20S CAR-T cells

BM2L201904

Phase 1 small_molecule terminated

Quick answer

LUCAR-20S CAR-T cells for Diffuse Large B Cell Lymphoma is a Phase 1 program (small_molecule) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Legend Biotech Corp
Indication
Diffuse Large B Cell Lymphoma
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials